Paving the way for anti-Abeta active immunotherapy
European Pharmaceutical Review
SEPTEMBER 22, 2023
She has extensive experience in the biopharmaceutical industry and previously served as Chief Scientific Officer for Novimmune from 2005.
This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.
European Pharmaceutical Review
SEPTEMBER 22, 2023
She has extensive experience in the biopharmaceutical industry and previously served as Chief Scientific Officer for Novimmune from 2005.
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content